- Home
- APLT vs MRAM Comparison
APLT vs MRAM Comparison
Compare APLT & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MRAM
- Stock Information
- Founded
- APLT 2016
- MRAM 2008
- Country
- APLT United States
- MRAM United States
- Employees
- APLT N/A
- MRAM N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MRAM Semiconductors
- Sector
- APLT Health Care
- MRAM Technology
- Exchange
- APLT Nasdaq
- MRAM Nasdaq
- Market Cap
- APLT 178.6M
- MRAM 150.5M
- IPO Year
- APLT 2019
- MRAM 2016
- Fundamental
- Price
- APLT $0.26
- MRAM $7.50
- Analyst Decision
- APLT Buy
- MRAM Strong Buy
- Analyst Count
- APLT 5
- MRAM 1
- Target Price
- APLT $4.13
- MRAM $10.50
- AVG Volume (30 Days)
- APLT 24.7M
- MRAM 251.2K
- Earning Date
- APLT 11-13-2025
- MRAM 11-05-2025
- Dividend Yield
- APLT N/A
- MRAM N/A
- EPS Growth
- APLT N/A
- MRAM N/A
- EPS
- APLT N/A
- MRAM N/A
- Revenue
- APLT $1,000,000.00
- MRAM $53,642,000.00
- Revenue This Year
- APLT N/A
- MRAM $10.80
- Revenue Next Year
- APLT $5,935.35
- MRAM $13.42
- P/E Ratio
- APLT N/A
- MRAM N/A
- Revenue Growth
- APLT N/A
- MRAM N/A
- 52 Week Low
- APLT $0.22
- MRAM $4.34
- 52 Week High
- APLT $10.48
- MRAM $12.27
- Technical
- Relative Strength Index (RSI)
- APLT 27.74
- MRAM 32.97
- Support Level
- APLT $0.26
- MRAM $8.30
- Resistance Level
- APLT $0.40
- MRAM $8.42
- Average True Range (ATR)
- APLT 0.12
- MRAM 0.55
- MACD
- APLT -0.07
- MRAM -0.24
- Stochastic Oscillator
- APLT 4.83
- MRAM 4.34
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).